Evinova
- Company typePrivate
- Founded2023
- HeadquartersBaar, Switzerland
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
Evinova firmographics
Firmographics- Name
- Evinova
- Legal name
- Evinova AG
- Website
- https://evinova.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Evinova industry classification
Industry- Product category
- Clinical Trial Technology
- NAICS
- Computer Systems Design Services (541512), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
Keywords
Where Evinova is headquartered
LocationHeadquarters
- HQ city
- Baar
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Evinova business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- AI-Native Platform Licensing: Enterprise software licensing of AI-native clinical development platform including Study Designer, Portfolio Management, and Unified Trial Solution modules. Platform has delivered hundreds of millions of dollars in multi-year savings for customers.
- Cost Optimizer Module: Deployment of Cost Optimizer module of Study Designer across global portfolios, generating efficiency and cost reduction for pharma customers.
- Consulting Services: Digital strategy consulting, regulatory consulting, evidence strategy, and endpoint validation services.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Evinova product offering
Product offeringCore offering
Evinova sells an AI-native clinical development platform that helps pharmaceutical companies, biotechs, and CROs design, plan, execute, and monitor clinical trials more efficiently. The platform includes the Unified Trial Solution for decentralized trial operations, Study Design & Optimization (Study Designer) with a Cost Optimizer module, Portfolio Management with predictive analytics, Study Document Assistant, and Remote Patient Monitoring, complemented by Digital Strategy Consulting services and Carbon Estimation & Reporting. Customers subscribe to enterprise licenses of these modular solutions and engage Evinova's consulting team for digital health strategy, regulatory, and evidence-generation support.
Product overview
Evinova offers a modular, AI-native clinical development platform comprising core products (Unified Trial Solution, Study Design & Optimization, Portfolio Management) within the Drug Development Suite, supplemented by specialized AI modules (AI Authoring, AI Digitizer, Cost Optimizer, Study Document Assistant), Remote Patient Monitoring capabilities, and strategic consulting services. The platform enables end-to-end clinical trial optimization from study design through execution, delivering proven outcomes including 60% improvement in patient experience, 32% cost reduction, and 6-month acceleration in trial delivery. Evinova operates as a separate health-tech business within the AstraZeneca Group, combining pharmaceutical expertise with AI-enabled digital solutions.
Differentiator
Problem solved
Functional benefit
Brands
- Study Designer: AI-native solution for clinical study design, optimization, costing, and benchmarking. Empowers clinical teams to design smarter, faster, and more cost-effective studies in minutes.
- Unified Trial Solution (UTS)
- Portfolio Management
- Study Document Assistant (SDA)
- Remote Patient Monitoring (RPM)
- Drug Development Suite
Products and services
- AI Platform End-to-end AI-enabled clinical development platform that streamlines operations, reduces burden, and drives faster decision-making across the clinical trial lifecycle through modular solutions including Study Design & Optimization, Portfolio Management, and Digital Trial Solutions, built on multi-tenant SaaS architecture with TLS 1.3 encryption and SAML 2.0 / OAuth 2.0 SSO.
- Unified Trial Solution (UTS) All-in-one digital clinical trial management platform connecting patients, investigative sites, and sponsors through a single integrated experience supporting decentralized trials, remote monitoring, eCOA, telehealth, and real-time data capture; supports 74% of assessments from home and reduces in-person clinical visits by up to 40%.
- Study Design & Optimization (Study Designer) AI-native study design and planning solution enabling teams to design optimal clinical studies in minutes with capabilities for cost estimation (97%+ accuracy), scenario comparison across cost, timelines, patient experience, and carbon emissions, feasibility assessment, protocol digitization, and accelerated authoring; integrates with Citeline's Sitetrove and Trialtrove intelligence databases.
- Portfolio Management Portfolio tracking and management solution providing real-time visibility into financial and clinical performance with AI-powered predictive recruitment curves at 94% accuracy, comparison against internal and external benchmarks, and proactive alerts identifying at-risk trials with recommended next-best actions.
- Drug Development Suite Umbrella product combining Study Design & Planning and Pipeline Management modules to increase transparency across the portfolio and empower decision-making at every level of the organization, providing end-to-end clinical development support across study design through execution.
- Study Document Assistant (SDA) AI-powered document navigation solution that simplifies clinical documentation workflows using a custom-trained AI model, reducing query resolution time by 80%, protocol amendment identification time by 50%, and health authority response time by 70% for clinical operations teams.
- Digital Strategy Consulting Expert-led consulting services blending deep scientific expertise with digital strategy including digital health strategy across therapy areas, regulatory consulting with global submission readiness, AI-powered patient recruitment cutting timelines by up to a year, and evidence-driven access and endpoint validation for life sciences sponsors.
- Recruitment by Design Digitally optimized patient recruitment service using AI and EHR analytics for precision-matched referrals, real-time funnel analytics, and conversion rates 4-5x higher than other digital recruitment methods, designed to cut recruitment timelines by up to a year.
- Carbon Estimation & Reporting End-to-end carbon emissions reporting and reduction solution for clinical trials including consulting services and a study design module with real-time carbon estimation and reduction recommendations, helping sponsors meet sustainability targets within clinical development.
Companies that use Evinova
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Evinova technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
Feature8 records
Evinova partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor, core, flagship and regional.
- Tufts Center for the Study of Drug DevelopmentminorResearch partnership with Tufts CSDD on digital tool adoption among investigative sites. Joint research study on how clinical research sites are investing in and using digital tools, with findings to be published.
- CitelinecoreMulti-year partnership integrating Citeline's clinical trial intelligence databases (Sitetrove with 500,000+ investigators and 190,000 trial sites; Trialtrove with curated real-world trial intelligence) into Evinova's AI-native Study Designer platform for data-driven optimization of clinical study design.
- Astellas PharmaflagshipStrategic collaboration where Astellas deploys Evinova's AI-native Study Designer platform to design smarter, more patient-centered studies, eliminate avoidable rework, and move with greater speed and precision in R&D. Partners share operational data with Evinova for benchmarking.
- AstraZenecaflagshipAstraZeneca continues collaboration with Evinova to harness AI for accelerating clinical development, improving productivity gains, delivering faster trials, and enhancing patient experience. Strategic collaboration reflects strong industry demand for AI-native platforms built specifically for clinical development.
- Bristol Myers SquibbflagshipBMS partners with Evinova to deploy the Cost Optimizer module of Study Designer across its global portfolio, leveraging advanced AI to improve insight-driven decision-making, identify productivity opportunities, and unlock more efficient trial designs.
- Harbour BioMedregionalEvinova China and Harbour BioMed announced strategic AI collaboration during CIIE to jointly apply AI and digital technologies to enhance efficiency of innovative biologics development and build an open ecosystem for AI-driven drug R&D.
- Quantum Leap Healthcare CollaborativecorePartnership to incorporate Evinova's Remote Patient Monitoring solution into I-SPY 2.2 breast cancer platform trial. RPM module monitors patients at risk of developing interstitial lung disease from treatments, enabling early identification and intervention.
- ParexelcoreFirst strategic collaboration with globally-leading CRO Parexel to offer Evinova's digital health solutions to their wide customer base, accelerating industry adoption.
- FortreacoreFirst strategic collaboration with globally-leading CRO Fortrea to offer Evinova's digital health solutions to their wide customer base, accelerating industry adoption.
- AccentureminorCollaboration with Accenture to accelerate industry adoption and sustain and expand the global reach of Evinova's digital products.
Scale indicators17 records
Recent moves7 records
Expansion highlights6 records
Evinova competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Largest CRO with broad digital clinical trial capabilities and proprietary technology platforms. Comparable as a broad incumbent offering overlapping clinical development technology and services at scale.
Emerging players
- Science 37: Decentralized clinical trial operator with proprietary patient-facing technology. Comparable as an emerging player in decentralized trial delivery, addressing similar pharma sponsors with remote-first trial designs.
- Saama Technologies: AI-driven clinical development analytics platform focused on trial operations and data insights. Comparable as an emerging AI-focused player addressing pharma clinical operations with predictive analytics similar to Evinova's Portfolio Management.
- Medable: Decentralized clinical trial platform with eCOA, telehealth, and eConsent. Comparable to Evinova's UTS decentralized trial capabilities, with similar focus on remote patient monitoring and digital endpoints.
- ArisGlobal: Life sciences platform provider with clinical trial, safety, and regulatory solutions including CTMS, EDC, and pharmacovigilance. Comparable as an emerging player with a broader life sciences R&D platform strategy.
- Castor: Cloud-based EDC and ePRO platform with focus on mid-market and academic sponsors. Comparable as an emerging EDC/eCOA competitor with modern, API-first architecture.
Direct peers
- Medidata (Dassault Systèmes): Industry-leading clinical trial platform (Rave EDC, eCOA, RTSM, CTMS) serving pharma and CROs. Directly comparable as a comprehensive clinical trial informatics platform competing for the same enterprise pharma sponsors.
- Oracle Clinical One: Oracle's unified clinical trial platform covering EDC, RTSM, eCOA, and patient engagement. Direct competitor for enterprise pharma platform deals with similar end-to-end trial scope.
- Clario: Specializes in eCOA, cardiac safety, and imaging for clinical trials. Directly comparable for the eCOA, telehealth, and connected device modules within Evinova's Unified Trial Solution.
- Veeva Systems: Life sciences cloud platform with Vault CTMS, Vault eTMF, and SiteVault. Directly comparable across clinical trial management and site operations, with Evinova already integrating with Veeva.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
Evinova social profiles
Digital presenceEvinova compliance and trust
Trust signalCompliance1 record
Evinova financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evinova leadership team
Management profileNumber of profiles
Profiles15 records
Evinova subsidiaries and ownership
Company hierarchySubsidiaries1 record
Evinova funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evinova M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evinova
What does Evinova do?
Evinova sells an AI-native clinical development platform that helps pharmaceutical companies, biotechs, and CROs design, plan, execute, and monitor clinical trials more efficiently. The platform includes the Unified Trial Solution for decentralized trial operations, Study Design & Optimization (Study Designer) with a Cost Optimizer module, Portfolio Management with predictive analytics, Study Document Assistant, and Remote Patient Monitoring, complemented by Digital Strategy Consulting services and Carbon Estimation & Reporting. Customers subscribe to enterprise licenses of these modular solutions and engage Evinova's consulting team for digital health strategy, regulatory, and evidence-generation support.
Is Evinova a public or private company?
Evinova is a private company. It is classified as corporate owned and is currently operating.
When was Evinova founded?
Evinova was founded in 2023. It employs 251 to 500 people.
Where is Evinova based?
Evinova is headquartered in Baar, Switzerland, in the Europe region.
How does Evinova make money?
Three revenue lines are on record. AI-Native Platform Licensing is the primary driver. The others are cost Optimizer Module and consulting Services.
Who are Evinova's main competitors?
IQVIA is listed as a broad incumbent. Emerging players are Science 37, Saama Technologies, Medable, ArisGlobal and Castor. Direct peers are Medidata (Dassault Systèmes), Oracle Clinical One, Clario and Veeva Systems.
Does Evinova have an API?
No public API is recorded for Evinova.
What industry is Evinova in?
Evinova's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 541512 and its SIC code is 7372.